C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2006
12/20/2006	CN1882345A 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of RAF kinase for treatment of cancer
12/20/2006	CN1880312A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same
12/20/2006	CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/20/2006	CN1880304A Triamide-substituted indoles, benzofuranes and benzothiophenes
12/20/2006	CN1290844C Dihydro Indolinone derivatives used as protein kinase inhibitor
12/20/2006	CN1290843C Polymorph of acid 4-[2-[4-[1-2-ethoxyethyl]-1h-benzimidazole-2-il]-1-piper idinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic acid
12/20/2006	CN1290842C Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
12/20/2006	CN1290501C Pharmaceutically active isoindoline derivatives
12/20/2006	CN1290500C Retroviral protease inhibitor combinations
12/19/2006	US7151180 3-((hetero)arylthio)-1,2-dihydroquinolin-2-ones such as 3-[(4-aminophenyl)thio]-4-(5-chloro-2-hydroxyphenyl)-6-(trifluoromethyl)-2(1H)-quinoline; erectile dysfunction and irritable bowel syndrome
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151116 Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells
12/19/2006	US7151113 Pyrazole-amine compounds useful as kinase inhibitors
12/19/2006	US7151111 Amine oxidase inhibitor; Alzheimer's disease
12/19/2006	US7151110 4-Methoxy-6-[3-(6-methyl-pyridin-2-yl)-1H-pyrazol-4-yl]-quinoline; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents
12/19/2006	US7151106 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
12/19/2006	US7151102 Phthalazinone derivatives
12/19/2006	US7151098 Glutamate receptor antagonists
12/19/2006	CA2275987C Acid addition salt of optically active piperidine compound and process for preparing the same
12/19/2006	CA2259538C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
12/19/2006	CA2209539C Phenol-free stabilization of polyolefin fibres
12/19/2006	CA2158863C Taxanes having a pyridyl substituted side-chain
12/14/2006	WO2006133303A1 Alpha 7 nicotinic receptor selective ligands
12/14/2006	WO2006132436A1 Heterocyclic compound
12/14/2006	WO2006132424A1 Process for production of 4(3h)-quinazolinone derivative
12/14/2006	WO2006132217A1 Crystal of salt of benzimidazole compound
12/14/2006	WO2006132192A1 Novel 2-quinolone derivative
12/14/2006	WO2006131835A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
12/14/2006	WO2006131711A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/14/2006	WO2006131519A1 Quinoline derivatives as antibacterial agents
12/14/2006	WO2006131491A1 Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenylamino]methyl}-1-methyl-1h-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate
12/14/2006	WO2006131338A2 Crystalline solvate of omeprazole sodium
12/14/2006	WO2006131303A2 Peptide deformylase (pdf) inhibitors 4
12/14/2006	WO2006131200A1 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament
12/14/2006	WO2006110884A8 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
12/14/2006	WO2006101977A3 Pyrimidine compounds and methods of use
12/14/2006	WO2006091575A3 Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
12/14/2006	WO2006084017A3 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
12/14/2006	WO2006049764A3 Methods of making 2,6-diaryl piperidine derivatives
12/14/2006	WO2006000336A3 Anthranilamides serving as pesticides
12/14/2006	WO2005100322A8 Sulphur-linked imidazole compounds for the treament of hiv
12/14/2006	WO2005075425A3 Substituted bisarylurea derivatives as kinase inhibitors
12/14/2006	US20060281784 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/14/2006	US20060281779 1 -cyclopropyl-7- [3-cyclopropylaminomethyl-4-fluoro-1 -pyrrolidinyl]-6-fluoro -1 ,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid; bactericide; against drug-resistant bacteria and against gram-positive bacteria, such as MRSA, PRSP and VRE
12/14/2006	US20060281774 Pyrimidine derivatives for the treatment of abnormal cell growth
12/14/2006	US20060281772 Alkylquinoline and alkylquinazoline kinase modulators
12/14/2006	US20060281743 Isoquinolinone potassium channel inhibitors
12/14/2006	US20060281740 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; biphenyl carbamic acid, piperidinyl ester derivatives
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060281733 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
12/14/2006	US20060281731 3,4,5-trihydroxy-2-methoxy-8,8-dimethyl-non-enoic acid ((3S,6S)-6-azido-2-oxo-azepan-3-yl)-amide; less toxicity, better selectivity in killing cancer cells, minimal effect on normal healthy cells
12/14/2006	US20060281727 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes
12/14/2006	US20060281726 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
12/14/2006	US20060281725 Agents and crystals for improving excretory potency of urinary bladder
12/14/2006	DE102005026231A1 Peptid-Deformylase (PDF) Inhibitoren 3 Peptide deformylase (PDF) inhibitors 3
12/14/2006	DE102005014936A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
12/14/2006	CA2611608A1 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof
12/14/2006	CA2611261A1 Crystal of salt of benzimidazole compound
12/14/2006	CA2610800A1 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament
12/14/2006	CA2610795A1 3-arylidene-anabaseine compounds as alpha 7 nicotitnic receptor selective ligands
12/14/2006	CA2610655A1 Cyclobutyl amine derivatives
12/14/2006	CA2610509A1 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
12/14/2006	CA2610304A1 Peptide deformylase (pdf) inhibitors 4
12/14/2006	CA2610172A1 Heterocyclic compound
12/14/2006	CA2609969A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/14/2006	CA2609583A1 Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenylamino]methyl}-1-methyl-1h-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate
12/13/2006	EP1731518A1 Cyclic amine compound and pest control agent
12/13/2006	EP1731511A1 BicyclischeI heterocycles, medicaments containing these compounds, their use and methods for the production thereof
12/13/2006	EP1731509A1 Process for producing nitrogenous 5-membered cyclic compound
12/13/2006	EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006	EP1730165A1 Inhibitors of hepatitis c virus ns3 protease
12/13/2006	EP1730152A2 Tetrahydroquinoline derivatives and a process for preparing the same
12/13/2006	EP1730142A1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
12/13/2006	EP1730137A1 Heterocyclic cgrp antagonists for the treatment of migraine
12/13/2006	EP1730136A1 N-piperidine derivates as ccr3 modulators
12/13/2006	EP1730135A1 Qiunolin-4-ones as inhibitors of retroviral integrase for the treatment of hiv, aids and aids related complex (arc)
12/13/2006	EP1730134A1 Pyridine inhibitors of erk2 and uses thereof
12/13/2006	EP1730124A1 Certain triazole-based compounds, compositions, and uses thereof
12/13/2006	EP1730122A2 Pyrimidine derivatives and methods of treatment related to the use thereof
12/13/2006	EP1730121A2 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
12/13/2006	EP1730119A1 Imidazole compounds for the treatment of neurodegenerative disorders
12/13/2006	EP1730118A1 Substituted azole derivatives, compositions, and methods of use
12/13/2006	EP1730116A1 4-carbox pyrazole derivates useful as anti-viral agents
12/13/2006	EP1730115A1 5-aminoalkylpyrazole derivatives as pesticidal agents
12/13/2006	EP1730114A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
12/13/2006	EP1730113A1 Process for the synthesis of a cxcr4 antagonist
12/13/2006	EP1730112A1 3-((hetero)arylsulfonyl)-8'[ (aminoalkyl)oxy]quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
12/13/2006	EP1730111A2 Substituted bisarylurea derivatives as kinase inhibitors
12/13/2006	EP1729818A2 Contrast agents for magnetic resonance imaging
12/13/2006	EP1729774A1 Pyrrolidine compounds
12/13/2006	EP1729772A2 Heteroaryl piperidine glycine transporter inhibitors
12/13/2006	EP1729723A1 Neutral and cationic naphthalene derivatives and dyes containing said compounds for dyeing keratin fibers
12/13/2006	EP1483241A4 Cyclic derivatives as modulators of chemokine receptor activity
12/13/2006	EP1478382B1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096
12/13/2006	EP1385823B1 Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
12/13/2006	CN1878771A Substituted bicyclic quinazolin-4-ylamine derivatives
12/13/2006	CN1878768A Heteroaryl deravatives as PPAR activators
12/13/2006	CN1878766A Methods for synthesizing quinolinone compounds
12/13/2006	CN1878765A Synthesis of quinoline 5-carboxamides useful for the preparation of PDE IV inhibitors
12/13/2006	CN1878764A Beta-lactams for treatment of cns disorders

1 ... 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 ... 1080